• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Protein zyg-11 homolog B (ZYG11B)

ACP10386

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10386 Target NameZYG11B
Target Synonymscell cycle regulator; ZYG11; Zyg11b, KIAA1730; Protein zyg-11 homolog B; ZY11B_HUMAN; zyg-11 family member BFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-744
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9C0D3
Background Information
  • Uniprot Id

    Q9C0D3

  • Target Species

    Human

  • Target Name

    ZYG11B

  • Target Full Name

    Protein zyg-11 homolog B

  • Target Function

    Serves as substrate adapter subunit in the E3 ubiquitin ligase complex ZYG11B-CUL2-Elongin BC. Acts redudantly with ZER1 to target substrates bearing N-terminal glycine degrons for proteasomal degradation. Involved in the clearance of proteolytic fragments generated by caspase cleavage during apoptosis since N-terminal glycine degrons are strongly enriched at caspase cleavage sites. Also important in the quality control of protein N-myristoylation in which N-terminal glycine degrons are conditionally exposed after a failure of N-myristoylation.

  • Target Protein Families

    Zyg-11 family

  • Target Synonyms

    KIAA1730; Protein zyg-11 homolog B; ZY11B_HUMAN; zyg-11 family member B, cell cycle regulator; ZYG11; Zyg11b

Inquire Recombinant Human Protein zyg-11 homolog B (ZYG11B) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification